These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2393663)

  • 1. Effects of dietary treatment with clofibrate, nafenopin or WY-14.643 on mitochondria and DNA in mouse liver.
    Lundgren B; Bergstrand A; Karlsson K; DePierre JW
    Biochim Biophys Acta; 1990 Aug; 1035(2):132-8. PubMed ID: 2393663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nafenopin and clofibrate on uptake and utilization of labeled thymidine for DNA synthesis in rat liver and kidney.
    Seifert J; Mostecká H
    Carcinogenesis; 1988 Jan; 9(1):3-8. PubMed ID: 2446797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of selenium in peroxisome proliferation caused by dietary administration of clofibrate to rats.
    Olsson U; Garberg P; Lundgren B; Andersson K; Hultenby K; Bergstrand A; Eriksson AM; Högberg J; DePierre JW
    Chem Biol Interact; 1992 Nov; 85(1):49-67. PubMed ID: 1458550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peroxisome proliferation-associated polypeptide in rat liver.
    Reddy JK; Kumar NS
    Biochem Biophys Res Commun; 1977 Aug; 77(3):824-9. PubMed ID: 901515
    [No Abstract]   [Full Text] [Related]  

  • 5. Is the cytosolic catalase induced by peroxisome proliferators in mouse liver on its way to the peroxisomes?
    Eriksson AM; Lundgren B; Andersson K; DePierre JW
    FEBS Lett; 1992 Aug; 308(2):211-4. PubMed ID: 1499733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators.
    Cai Y; Appelkvist EL; DePierre JW
    J Biochem Toxicol; 1995 Apr; 10(2):87-94. PubMed ID: 7562957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hypolipidemic drugs, nafenopin and clofibrate, on the concentration of ligandin and Z protein in rat liver.
    Fleischner G; Meijer DK; Levine WG; Gatmaitan Z; Gluck R; Arias IM
    Biochem Biophys Res Commun; 1975 Dec; 67(4):1401-7. PubMed ID: 812503
    [No Abstract]   [Full Text] [Related]  

  • 8. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
    Gerbracht U; Bursch W; Kraus P; Putz B; Reinacher M; Timmermann-Trosiener I; Schulte-Hermann R
    Carcinogenesis; 1990 Apr; 11(4):617-24. PubMed ID: 1691053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of peroxisomal enzymes in livers of neonatal rats exposed to lactating mothers treated with hypolipidaemic drugs. Role of drug metabolite transfer in milk.
    Fahl WE; Lalwani ND; Reddy MK; Reddy JK
    Biochem J; 1983 Mar; 210(3):875-83. PubMed ID: 6683505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
    Eacho PI; Lanier TL; Brodhecker CA
    Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two hypolipidemic peroxisome proliferators increase the number of lamellar bodies in alveolar cells type II of the rat lung.
    Fringes B; Reith A
    Exp Mol Pathol; 1988 Apr; 48(2):262-71. PubMed ID: 3258252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the major integral membrane protein of mouse liver peroxisomes by peroxisome proliferators.
    Chen N; Crane DI
    Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):605-10. PubMed ID: 1575703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J; Svoboda D; Azarnoff D
    Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
    [No Abstract]   [Full Text] [Related]  

  • 15. Perturbation by clofibrate of mitochondrial levels in animal cells. Implications for a model of mitochondrial genesis.
    Lipsky NG; Pedersen PL
    J Biol Chem; 1982 Feb; 257(3):1473-81. PubMed ID: 7056728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of clofibrate on intracellular enzyme distribution in the rat liver].
    Panchenko LF; Popova SV; Pirozhkov SV; Antonenkov VD
    Tsitologiia; 1983 Nov; 25(11):1302-8. PubMed ID: 6659071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of pyrimidine and nucleic acid synthesis during adaptive growth of liver induced by nafenopin, a peroxisome proliferator. An in vivo study.
    Seifert J; Mostecká H
    Carcinogenesis; 1989 Aug; 10(8):1383-8. PubMed ID: 2473851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.
    Leighton F; Coloma L; Koenig C
    J Cell Biol; 1975 Nov; 67(2PT.1):281-309. PubMed ID: 406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in hepatic catalase and glycerol phosphate dehydrogenase activities on administration of clofibrate and clofenapate to the rat.
    Krishnakantha TP; Kurup CK
    Biochem J; 1972 Nov; 130(1):167-75. PubMed ID: 4655418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.